Associations between fecal bile acids, neutral sterols, and serum lipids in the KORA FF4 study

Associations between fecal bile acids, neutral sterols, and serum lipids in the KORA FF4 study
复制标题

KORA FF 4研究中粪便胆汁酸、中性固醇和血脂之间的相关性

DOI:
10.1016/j.atherosclerosis.2019.06.911
复制
发表时间:
2019-09-01
期刊:
影响因子:
5.3
通讯作者:
Linseisen, Jakob
Linseisen, Jakob
中科院分区:
医学2区
文献类型:
--
作者:
Breuninger, Taylor A.;Wawro, Nina;Linseisen, Jakob

文献摘要

被引文献

相似文献

Background and aims: Dyslipidemia is a major risk factor for cardiovascular disease, the leading cause of preventable death worldwide. As a result, a full understanding of the factors influencing dyslipidemia is urgently necessary. Bile acids have been recognized as regulators of lipid metabolism, and neutral sterols may influence serum lipid levels. Therefore, this analysis was conducted to better understand the relationship between bile acids, neutral sterols, and dyslipidemia.Methods: We examined cross-sectional associations between selected fecal metabolites and serum lipids or markers of dyslipidemia in 1387 participants of the KORA FF4 study using linear and logistic regression models.Results: We found positive associations between fecal bile acids and serum high-density lipoprotein cholesterol, low-density lipoprotein cholesterol (LDL-c), total cholesterol, triglycerides and markers of dyslipidemia, though associations were seen most consistently with triglycerides and hypertriglyceridemia. We also found positive associations between fecal cholesterol and serum LDL-c, total cholesterol, triglycerides, hypertriglyceridemia and high serum total cholesterol, though only associations with triglycerides or hypertriglyceridemia remained significant after applying the Bonferroni correction. Unexpectedly, several fecal plant sterols were positively associated with serum lipids and the associated markers of dyslipidemia. However, many of these associations were no longer statistically significant after adjusting for multiple testing.Conclusions: Our results provide insight into the role that bile acids may play in the development or progression of dyslipidemia. However, further confirmation of these results is warranted. Longitudinal and experimental studies are necessary to clarify the mechanisms behind these associations and to determine causality.